APO Research
Talk to an analyst

APO RESEARCH · REPORT

Loratadine

Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms. Loratadine is also used to treat skin hives and itching in people with chronic skin reactions. Notes: This report is statistical data of loratadine API.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms. Loratadine is also used to treat skin hives and itching in people with chronic skin reactions. Notes: This report is statistical data of loratadine API.

Selected research

Market Outlook & Growth Opportunities

Global Loratadine Market Outlook and Growth Opportunities 2026

9 January 2026195 pages

Choose your research edition.

Industry ResearchLoratadine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Loratadine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Loratadine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Loratadine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Loratadine Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

Loratadine is an antihistamine that reduces the effects of natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose. Loratadine is used to treat sneezing, runny nose, watery eyes, hives, skin rash, itching, and other cold or allergy symptoms. Loratadine is also used to treat skin hives and itching in people with chronic skin reactions. Notes: This report is statistical data of loratadine API.

Global Loratadine key players include Cadila Pharmaceuticals, Morepen, Merck Group, Ultratech India Limited, Vasudha Pharma Chem, etc. Global top five manufacturers hold a share about 50%. India is the largest market, with a share about 60%, followed by North America and Europe, total have a share over 25 percent. In terms of product, Pharmaceutical Standards Grade is the largest segment, with a share about 30%. And in terms of application, the largest application is Loratadine Tablet, followed by Loratadine Capsule, and Loratadine Syrup.

This report provides an overview of the global Loratadine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Loratadine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Loratadine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Loratadine market size, projected growth trends, production technologies, key applications, and end-use industries.

Loratadine Segment by Company

Merck

Cadila Pharmaceuticals

Morepen

Ultratech India

Vasudha Pharma Chem

Hetero Drugs

Mylan

Changzhou Yabang

Shaanxi Hanjiang

Inke, S.A.

Argon Drugs

Loratadine Segment by Type

USP Standards Grade

EP Standards Grade

Pharmaceutical Standards Grade

Others

Loratadine Segment by Application

Loratadine Tablet

Loratadine Capsules

Loratadine Syrup

Others

Loratadine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Loratadine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Loratadine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Loratadine significant trends, drivers, influence factors in global and regions.

6. To analyze Loratadine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Loratadine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Loratadine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Loratadine industry.

Chapter 3: Detailed analysis of Loratadine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Loratadine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Loratadine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Loratadine Industry Trends Table 2. Loratadine Industry Drivers Table 3. Loratadine Industry Opportunities and Challenges Table 4. Loratadine Industry Restraints Table 5. Global Loratadine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Loratadine Revenue Share by Company (2021-2026) Table 7. Global Loratadine Sales Volume by Company (MT) & (2021-2026) Table 8. Global Loratadine Sales Volume Share by Company (2021-2026) Table 9. Global Loratadine Average Price (USD/MT) of Company (2021-2026) Table 10. Global Loratadine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Loratadine Key Company Manufacturing Base & Headquarters Table 12. Global Loratadine Company, Product Type & Application Table 13. Global Loratadine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Loratadine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of USP Standards Grade Table 18. Significant Companies of EP Standards Grade Table 19. Significant Companies of Pharmaceutical Standards Grade Table 20. Significant Companies of Others Table 21. Global Loratadine Sales Volume by Type 2021 VS 2025 VS 2032 (MT) Table 22. Global Loratadine Sales Volume by Type (2021-2026) & (MT) Table 23. Global Loratadine Sales Volume by Type (2027-2032) & (MT) Table 24. Global Loratadine Sales Volume Share by Type (2021-2026) Table 25. Global Loratadine Sales Volume Share by Type (2027-2032) Table 26. Global Loratadine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Loratadine Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Loratadine Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Loratadine Sales Value Share by Type (2021-2026) Table 30. Global Loratadine Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Loratadine Tablet Table 32. Significant Companies of Loratadine Capsules Table 33. Significant Companies of Loratadine Syrup Table 34. Significant Companies of Others Table 35. Global Loratadine Sales Volume by Application 2021 VS 2025 VS 2032 (MT) Table 36. Global Loratadine Sales Volume by Application (2021-2026) & (MT) Table 37. Global Loratadine Sales Volume by Application (2027-2032) & (MT) Table 38. Global Loratadine Sales Volume Share by Application (2021-2026) Table 39. Global Loratadine Sales Volume Share by Application (2027-2032) Table 40. Global Loratadine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Loratadine Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Loratadine Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Loratadine Sales Value Share by Application (2021-2026) Table 44. Global Loratadine Sales Value Share by Application (2027-2032) Table 45. Global Loratadine Sales by Region: 2021 VS 2025 VS 2032 (MT) Table 46. Global Loratadine Sales by Region (2021-2026) & (MT) Table 47. Global Loratadine Sales Market Share by Region (2021-2026) Table 48. Global Loratadine Sales by Region (2027-2032) & (MT) Table 49. Global Loratadine Sales Market Share by Region (2027-2032) Table 50. Global Loratadine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Loratadine Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Loratadine Sales Value Share by Region (2021-2026) Table 53. Global Loratadine Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Loratadine Sales Value Share by Region (2027-2032) Table 55. Global Loratadine Market Average Price (USD/MT) by Region (2021-2026) Table 56. Global Loratadine Market Average Price (USD/MT) by Region (2027-2032) Table 57. Global Loratadine Sales by Country: 2021 VS 2025 VS 2032 (MT) Table 58. Global Loratadine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Loratadine Sales by Country (2021-2026) & (MT) Table 60. Global Loratadine Sales Market Share by Country (2021-2026) Table 61. Global Loratadine Sales by Country (2027-2032) & (MT) Table 62. Global Loratadine Sales Market Share by Country (2027-2032) Table 63. Global Loratadine Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Loratadine Sales Value Market Share by Country (2021-2026) Table 65. Global Loratadine Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Loratadine Sales Value Market Share by Country (2027-2032) Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 70. Merck Loratadine Product Portfolio Table 71. Merck Recent Development Table 72. Cadila Pharmaceuticals Company Information Table 73. Cadila Pharmaceuticals Business Overview Table 74. Cadila Pharmaceuticals Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 75. Cadila Pharmaceuticals Loratadine Product Portfolio Table 76. Cadila Pharmaceuticals Recent Development Table 77. Morepen Company Information Table 78. Morepen Business Overview Table 79. Morepen Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 80. Morepen Loratadine Product Portfolio Table 81. Morepen Recent Development Table 82. Ultratech India Company Information Table 83. Ultratech India Business Overview Table 84. Ultratech India Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 85. Ultratech India Loratadine Product Portfolio Table 86. Ultratech India Recent Development Table 87. Vasudha Pharma Chem Company Information Table 88. Vasudha Pharma Chem Business Overview Table 89. Vasudha Pharma Chem Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 90. Vasudha Pharma Chem Loratadine Product Portfolio Table 91. Vasudha Pharma Chem Recent Development Table 92. Hetero Drugs Company Information Table 93. Hetero Drugs Business Overview Table 94. Hetero Drugs Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 95. Hetero Drugs Loratadine Product Portfolio Table 96. Hetero Drugs Recent Development Table 97. Mylan Company Information Table 98. Mylan Business Overview Table 99. Mylan Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 100. Mylan Loratadine Product Portfolio Table 101. Mylan Recent Development Table 102. Changzhou Yabang Company Information Table 103. Changzhou Yabang Business Overview Table 104. Changzhou Yabang Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 105. Changzhou Yabang Loratadine Product Portfolio Table 106. Changzhou Yabang Recent Development Table 107. Shaanxi Hanjiang Company Information Table 108. Shaanxi Hanjiang Business Overview Table 109. Shaanxi Hanjiang Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 110. Shaanxi Hanjiang Loratadine Product Portfolio Table 111. Shaanxi Hanjiang Recent Development Table 112. Inke, S.A. Company Information Table 113. Inke, S.A. Business Overview Table 114. Inke, S.A. Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 115. Inke, S.A. Loratadine Product Portfolio Table 116. Inke, S.A. Recent Development Table 117. Argon Drugs Company Information Table 118. Argon Drugs Business Overview Table 119. Argon Drugs Loratadine Sales (MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 120. Argon Drugs Loratadine Product Portfolio Table 121. Argon Drugs Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Loratadine Distributors List Table 125. Loratadine Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Loratadine Product Image Figure 2. Global Loratadine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Loratadine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Loratadine Sales (2021-2032) & (MT) Figure 5. Global Loratadine Sales Average Price (USD/MT) & (2021-2032) Figure 6. Global Loratadine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. USP Standards Grade Image Figure 10. EP Standards Grade Image Figure 11. Pharmaceutical Standards Grade Image Figure 12. Others Image Figure 13. Global Loratadine Sales Volume by Type (2021 VS 2025 VS 2032) & (MT) Figure 14. Global Loratadine Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Loratadine Sales Volume Share by Type (2021-2032) Figure 16. Global Loratadine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Loratadine Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Loratadine Sales Value Share by Type (2021-2032) Figure 19. Loratadine Tablet Image Figure 20. Loratadine Capsules Image Figure 21. Loratadine Syrup Image Figure 22. Others Image Figure 23. Global Loratadine Sales Volume by Application (2021 VS 2025 VS 2032) & (MT) Figure 24. Global Loratadine Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Loratadine Sales Volume Share by Application (2021-2032) Figure 26. Global Loratadine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Loratadine Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Loratadine Sales Value Share by Application (2021-2032) Figure 29. Global Loratadine Sales by Region: 2021 VS 2025 VS 2032 (MT) Figure 30. Global Loratadine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Loratadine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Loratadine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Loratadine Sales Value (2021-2032) & (US$ Million) Figure 34. North America Loratadine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Loratadine Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Loratadine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Loratadine Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Loratadine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Loratadine Sales Value (2021-2032) & (US$ Million) Figure 40. South America Loratadine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Loratadine Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Loratadine Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Loratadine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Loratadine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Loratadine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Loratadine Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Loratadine Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • USP Standards Grade
  • EP Standards Grade
  • Pharmaceutical Standards Grade
  • Others
Applications
  • Loratadine Tablet
  • Loratadine Capsules
  • Loratadine Syrup
  • Others
Companies covered
  • Merck
  • Cadila Pharmaceuticals
  • Morepen
  • Ultratech India
  • Vasudha Pharma Chem
  • Hetero Drugs
  • Mylan
  • Changzhou Yabang
  • Shaanxi Hanjiang
  • Inke, S.A.
  • Argon Drugs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Loratadine Sales Value (2021-2032)
  4. 1.2.2 Global Loratadine Sales Volume (2021-2032)
  5. 1.2.3 Global Loratadine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Loratadine Market Dynamics
  1. 2.1 Loratadine Industry Trends
  2. 2.2 Loratadine Industry Drivers
  3. 2.3 Loratadine Industry Opportunities and Challenges
  4. 2.4 Loratadine Industry Restraints
3 Loratadine Market by Company
  1. 3.1 Global Loratadine Company Revenue Ranking in 2025
  2. 3.2 Global Loratadine Revenue by Company (2021-2026)
  3. 3.3 Global Loratadine Sales Volume by Company (2021-2026)
  4. 3.4 Global Loratadine Average Price by Company (2021-2026)
  5. 3.5 Global Loratadine Company Ranking (2024-2026)
  6. 3.6 Global Loratadine Company Manufacturing Base and Headquarters
  7. 3.7 Global Loratadine Company Product Type and Application
  8. 3.8 Global Loratadine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Loratadine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Loratadine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Loratadine Market by Type
  1. 4.1 Loratadine Type Introduction
  2. 4.1.1 USP Standards Grade
  3. 4.1.2 EP Standards Grade
  4. 4.1.3 Pharmaceutical Standards Grade
  5. 4.1.4 Others
  6. 4.2 Global Loratadine Sales Volume by Type
  7. 4.2.1 Global Loratadine Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Loratadine Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Loratadine Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Loratadine Sales Value by Type
  11. 4.3.1 Global Loratadine Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Loratadine Sales Value by Type (2021-2032)
  13. 4.3.3 Global Loratadine Sales Value Share by Type (2021-2032)
5 Loratadine Market by Application
  1. 5.1 Loratadine Application Introduction
  2. 5.1.1 Loratadine Tablet
  3. 5.1.2 Loratadine Capsules
  4. 5.1.3 Loratadine Syrup
  5. 5.1.4 Others
  6. 5.2 Global Loratadine Sales Volume by Application
  7. 5.2.1 Global Loratadine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Loratadine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Loratadine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Loratadine Sales Value by Application
  11. 5.3.1 Global Loratadine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Loratadine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Loratadine Sales Value Share by Application (2021-2032)
6 Loratadine Regional Sales and Value Analysis
  1. 6.1 Global Loratadine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Loratadine Sales by Region (2021-2032)
  3. 6.2.1 Global Loratadine Sales by Region: 2021-2026
  4. 6.2.2 Global Loratadine Sales by Region (2027-2032)
  5. 6.3 Global Loratadine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Loratadine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Loratadine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Loratadine Sales Value by Region (2027-2032)
  9. 6.5 Global Loratadine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Loratadine Sales Value (2021-2032)
  12. 6.6.2 North America Loratadine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Loratadine Sales Value (2021-2032)
  15. 6.7.2 Europe Loratadine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Loratadine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Loratadine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Loratadine Sales Value (2021-2032)
  21. 6.9.2 South America Loratadine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Loratadine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Loratadine Sales Value Share by Country, 2025 VS 2032
7 Loratadine Country-level Sales and Value Analysis
  1. 7.1 Global Loratadine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Loratadine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Loratadine Sales by Country (2021-2032)
  4. 7.3.1 Global Loratadine Sales by Country (2021-2026)
  5. 7.3.2 Global Loratadine Sales by Country (2027-2032)
  6. 7.4 Global Loratadine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Loratadine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Loratadine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Loratadine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Loratadine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Loratadine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Loratadine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Loratadine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Loratadine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Loratadine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Loratadine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Loratadine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Loratadine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Loratadine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Loratadine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Loratadine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Loratadine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Loratadine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Loratadine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Loratadine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Loratadine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Loratadine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Loratadine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Loratadine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Loratadine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Loratadine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Loratadine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Loratadine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Loratadine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Loratadine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Loratadine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Loratadine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Loratadine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Loratadine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Loratadine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Loratadine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Loratadine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Loratadine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Loratadine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Loratadine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Loratadine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Loratadine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Loratadine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Loratadine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Loratadine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Loratadine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Loratadine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Loratadine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Loratadine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Loratadine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Loratadine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Loratadine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Loratadine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Loratadine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Loratadine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Loratadine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Loratadine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Loratadine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Loratadine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Loratadine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Loratadine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Loratadine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Loratadine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Loratadine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Loratadine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Loratadine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Loratadine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Loratadine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Loratadine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Loratadine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Loratadine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Loratadine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Loratadine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Loratadine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Loratadine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Loratadine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Loratadine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Loratadine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Loratadine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Loratadine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Loratadine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Loratadine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Loratadine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Loratadine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Loratadine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Loratadine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Loratadine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Loratadine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Merck Loratadine Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Cadila Pharmaceuticals
  8. 8.2.1 Cadila Pharmaceuticals Company Information
  9. 8.2.2 Cadila Pharmaceuticals Business Overview
  10. 8.2.3 Cadila Pharmaceuticals Loratadine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cadila Pharmaceuticals Loratadine Product Portfolio
  12. 8.2.5 Cadila Pharmaceuticals Recent Developments
  13. 8.3 Morepen
  14. 8.3.1 Morepen Company Information
  15. 8.3.2 Morepen Business Overview
  16. 8.3.3 Morepen Loratadine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Morepen Loratadine Product Portfolio
  18. 8.3.5 Morepen Recent Developments
  19. 8.4 Ultratech India
  20. 8.4.1 Ultratech India Company Information
  21. 8.4.2 Ultratech India Business Overview
  22. 8.4.3 Ultratech India Loratadine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ultratech India Loratadine Product Portfolio
  24. 8.4.5 Ultratech India Recent Developments
  25. 8.5 Vasudha Pharma Chem
  26. 8.5.1 Vasudha Pharma Chem Company Information
  27. 8.5.2 Vasudha Pharma Chem Business Overview
  28. 8.5.3 Vasudha Pharma Chem Loratadine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vasudha Pharma Chem Loratadine Product Portfolio
  30. 8.5.5 Vasudha Pharma Chem Recent Developments
  31. 8.6 Hetero Drugs
  32. 8.6.1 Hetero Drugs Company Information
  33. 8.6.2 Hetero Drugs Business Overview
  34. 8.6.3 Hetero Drugs Loratadine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hetero Drugs Loratadine Product Portfolio
  36. 8.6.5 Hetero Drugs Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Loratadine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Loratadine Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Changzhou Yabang
  44. 8.8.1 Changzhou Yabang Company Information
  45. 8.8.2 Changzhou Yabang Business Overview
  46. 8.8.3 Changzhou Yabang Loratadine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Changzhou Yabang Loratadine Product Portfolio
  48. 8.8.5 Changzhou Yabang Recent Developments
  49. 8.9 Shaanxi Hanjiang
  50. 8.9.1 Shaanxi Hanjiang Company Information
  51. 8.9.2 Shaanxi Hanjiang Business Overview
  52. 8.9.3 Shaanxi Hanjiang Loratadine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Shaanxi Hanjiang Loratadine Product Portfolio
  54. 8.9.5 Shaanxi Hanjiang Recent Developments
  55. 8.10 Inke, S.A.
  56. 8.10.1 Inke, S.A. Company Information
  57. 8.10.2 Inke, S.A. Business Overview
  58. 8.10.3 Inke, S.A. Loratadine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Inke, S.A. Loratadine Product Portfolio
  60. 8.10.5 Inke, S.A. Recent Developments
  61. 8.11 Argon Drugs
  62. 8.11.1 Argon Drugs Company Information
  63. 8.11.2 Argon Drugs Business Overview
  64. 8.11.3 Argon Drugs Loratadine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Argon Drugs Loratadine Product Portfolio
  66. 8.11.5 Argon Drugs Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Loratadine Value Chain Analysis
  2. 9.1.1 Loratadine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Loratadine Sales Mode & Process
  6. 9.2 Loratadine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Loratadine Distributors
  9. 9.2.3 Loratadine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst